Fund profile
Tickers
GNOM
Fund manager
Total assets
$84.83 mm
Liabilities
$34.44 k
Net assets
$84.80 mm
Number of holdings
43.00
GNOM stock data
43 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | 5.42 mm | 20.62 k shares | 6.39 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 4.60 mm | 104.48 k shares | 5.42 | Common equity | Long | USA |
BNYREPOS | 4.09 mm | 4.09 mm principal | 4.82 | Repurchase agreement | Long | USA |
NTRA Natera, Inc. | 3.83 mm | 32.40 k shares | 4.52 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 3.80 mm | 66.98 k shares | 4.49 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 3.78 mm | 65.66 k shares | 4.46 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 3.57 mm | 125.96 k shares | 4.21 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 3.46 mm | 46.73 k shares | 4.08 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 3.41 mm | 108.09 k shares | 4.02 | Common equity | Long | USA |
QGEN Qiagen N.V. | 3.27 mm | 71.44 k shares | 3.85 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 3.24 mm | 23.87 k shares | 3.82 | Common equity | Long | USA |
ILMN Illumina, Inc. | 3.17 mm | 24.14 k shares | 3.74 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 3.10 mm | 137.97 k shares | 3.65 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 3.08 mm | 21.57 k shares | 3.64 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 3.03 mm | 127.35 k shares | 3.58 | Common equity | Long | USA |
BNTX BioNTech SE | 2.97 mm | 33.67 k shares | 3.50 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 2.97 mm | 32.53 k shares | 3.50 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 2.65 mm | 99.32 k shares | 3.12 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 2.54 mm | 53.33 k shares | 3.00 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 2.52 mm | 107.94 k shares | 2.97 | Common equity | Long | USA |
GENSCRIPT BIOTECH CORP COMMON STOCK
|
2.40 mm | 1.59 mm shares | 2.83 | Common equity | Long | Hong Kong |
RCKT Rocket Pharmaceuticals, Inc. | 2.32 mm | 123.05 k shares | 2.74 | Common equity | Long | USA |
CDNA CareDx, Inc | 2.21 mm | 71.97 k shares | 2.61 | Common equity | Long | USA |
MRNA Moderna, Inc. | 2.11 mm | 27.23 k shares | 2.49 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 1.83 mm | 3.68 k shares | 2.15 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 1.75 mm | 22.11 k shares | 2.06 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 1.08 mm | 130.57 k shares | 1.27 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 1.06 mm | 175.29 k shares | 1.25 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 787.68 k | 64.46 k shares | 0.93 | Common equity | Long | USA |
FLGT Fulgent Genetics, Inc. | 656.16 k | 29.09 k shares | 0.77 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 530.61 k | 79.20 k shares | 0.63 | Common equity | Long | USA |
NxStage Medical, Inc. | 515.01 k | 375.92 k shares | 0.61 | Common equity | Long | USA |
TAKARA BIO INC COMMON STOCK
|
482.03 k | 67.42 k shares | 0.57 | Common equity | Long | Japan |
EDIT Editas Medicine, Inc. | 439.89 k | 117.62 k shares | 0.52 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 401.61 k | 152.70 k shares | 0.47 | Common equity | Long | USA |
QURE uniQure N.V. | 364.53 k | 62.31 k shares | 0.43 | Common equity | Long | USA |
TSVT 2seventy bio, Inc. | 335.58 k | 68.91 k shares | 0.40 | Common equity | Long | USA |
PSTX Poseida Therapeutics, Inc. | 301.95 k | 105.58 k shares | 0.36 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 247.54 k | 170.72 k shares | 0.29 | Common equity | Long | USA |
CRBU Caribou Biosciences, Inc. | 244.07 k | 112.99 k shares | 0.29 | Common equity | Long | USA |
BLUE bluebird bio, Inc. | 153.41 k | 273.22 k shares | 0.18 | Common equity | Long | USA |
SCILEX HOLDING CO - RESTRICTED SPECIAL PURPOSE ACQUISITION COMPANIES
|
65.00 k | 226.07 k shares | 0.08 | Common equity | Long | USA |
GRAL GRAIL, LLC | 57.83 k | 4.10 k shares | 0.07 | Common equity | Long | USA |